Sectors & markets
Singapore Strengthens Genomic Testing Capabilities with New NUHS Center
PHOTO: The Straits Times
Market Info | Health & Lifestyle | Medical Genetics
Date: 1 May 2026
Region: ASEAN-O
Country: Singapore
Sector: Health & Lifestyle
Sub-sector: Medical Genetics
Section: Market Trends
Theme: Medical Innovation and Personalized Medicine
Singapore is taking a significant step forward in personalized medicine with the opening of a dedicated genomic testing center within the National University Health System (NUHS). Announced in April 2026, this center aims to expand access to genomic analysis for patients with cancers, rare diseases, and metabolic disorders, enabling more precise diagnoses and tailored treatments based on individual genetic profiles.
According to The Straits Times, the new center seeks to triple the annual number of genomic tests, increasing from 2,000 to over 6,000 by 2027. This expansion is supported by an investment of SGD 20 million (approximately €13 million) and partnerships with international laboratories to integrate the latest advancements in genetic sequencing technology.
The initiative aligns with Singapore’s national "Precision Medicine Singapore" strategy, which aims to position the country as a regional leader in precision medicine. Genomic testing allows for the identification of specific mutations, optimization of cancer therapies, and reduction of side effects from traditional treatments. For example, patients with lung or breast cancer could benefit from targeted protocols, improving their survival rates by 25%, according to local clinical studies.
The center will also collaborate with public hospitals and private clinics to train healthcare professionals and raise public awareness about the importance of genomics in disease prevention and treatment. This initiative reaffirms Singapore’s commitment to integrating medical innovation to address the needs of its aging population and the rising prevalence of chronic diseases.
